Millidrop

Paris, France Founded: 2015 • Age: 11 yrs
Benchtop instruments for parallel bacteriological cell analysis are developed.

About Millidrop

Millidrop is a company based in Paris (France) founded in 2015. Millidrop has raised $1.13 million across 5 funding rounds from investors including Bpifrance, European Union and EIC Fund. Millidrop offers products and services including MilliDrop AzurEvo, OT-2 Liquid Handler, Bolt ELISA Analyzer, and ThunderBolt ELISA Analyzer. Millidrop operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.

Key Metrics
  • Total Equity Funding
    $1.13M (USD)

    in 5 rounds

  • Latest Funding Round
    $2.2M (USD), Debt – Conventional

    Sep 2018

  • Investors
    Bpifrance

    & 3 more

Products & Services of Millidrop

Millidrop offers a comprehensive portfolio of products and services, including MilliDrop AzurEvo, OT-2 Liquid Handler, Bolt ELISA Analyzer, and ThunderBolt ELISA Analyzer.

MilliDrop AzurEvo
Microbiology Screening

Platform for high-throughput micro-organism phenotyping and analysis

OT-2 Liquid Handler
Laboratory Automation

Automated system for precise liquid handling in diagnostics

Bolt ELISA Analyzer
Diagnostic Analysis

Instrument for enzyme-linked immunosorbent assay testing

ThunderBolt ELISA Analyzer
Diagnostic Analysis

Advanced analyzer for ELISA-based pathogen detection

Apps and channels of Millidrop

its YouTube channel Gold Standard Diagnostics has 482 subscribers and 30 videos.

Gold Standard Diagnostics
YouTube 482 subscribers 30 videos Science & Technology
Open channel

Videos from Millidrop

The most watched videos on Millidrop's YouTube channel, Gold Standard Diagnostics (482 subscribers). Click a video to play it here.

GSD NovaGen SARS-CoV-2 Antigen Rapid Self-Test (Nasal Swab) – How to Use
6.4K views
The BOLT - Fully-automated, one-plate ELISA+CLIA processor
4.5K views
GSD SENSISpec Allergen Test Kits and Automation
2.3K views
Gold Standard Diagnostics Corporate Video
1.9K views

More on Gold Standard Diagnostics.

Funding Insights of Millidrop

Millidrop has successfully raised a total of $1.13M across 5 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.2 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.13M
  • Total Rounds 5
  • Last Round Debt – Conventional β€” $2.2M
  • First Round $1.13M

    (Jan 2016)

  • Investors Count 4

All 5 funding rounds of Millidrop with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2018$2.2MDebt – Conventional––
Jan 2018$61,968Grant––
Aug 2017$59,000Grant––
Jan 2017$52,644Grant––
Jan 2016$1.13MSeed––
Valuation history

4 investors in total: 4 institutional.

Investors in Millidrop

Millidrop has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Bpifrance, European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
–eicfund.euBrussels, Belgium
Tech & Life Sciences focused stage agnostic VC firm investing in Europe, Asia & the US
–seventure.frParis, France
Corporate consultancy, advisory, and funding services are provided to businesses.
2012bpifrance.comMaisons Alfort, France
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Millidrop

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Millidrop

3 dated milestones of Millidrop across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Millidrop is founded.
  2. Funding First funding round of $1.1M.
  3. Funding Latest funding round, Debt – Conventional, of $2.2M.

Competitors of Millidrop

Millidrop operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
10xgenomics.com2012Pleasanton, United States$199.9M961
Instrument systems for genomic research and sequencing libraries are developed.
missionbio.com2014San Francisco, United States$110M109
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
cellares.com2019San Francisco, United States$355M–
Medical devices for cell-based therapy manufacturing are produced.
lumicks.com2014Amsterdam, Netherlands$93.38M–
Optical tweezers instruments for single-molecule analysis are manufactured.
levitasbio.com2017San Francisco, United States$73.77M–
Single-cell imaging platform developed via magnetic levitation technology.
biomesense.com2018Chicago, United States$8.43M9
AI-enabled platform for microbiome data generation and analysis is developed.
ogibio.co.uk2020Penicuik, United Kingdom$4.57M8
Modular automation system for routine microbial culturing is provided.
rebusbio.com2006Santa Clara, United States$20M–
An imaging system for single-cell gene analysis is developed.
atrandi.com2016Vilnius, Lithuania$31.01M–
Microfluidic solutions for life sciences and single-cell analysis are developed.
Premium access

Detailed competitors of Millidrop

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Millidrop

Premium access

Complete news archive for Millidrop

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Millidrop

10 companies that operate in the same segment as Millidrop (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Millidrop

Millidrop was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Millidrop is headquartered in Paris, France.

Millidrop is a funded company, having raised a total of $1.13M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.13M, raised on Jan 2016.

The company was founded in 2015 in Paris, France, and operates in the biotechnology sector. Benchtop automated instruments are developed by it to handle and analyze up to 10,000 reactions in parallel, utilizing milli fluidics technology. Focus is placed on bacteriological research and diagnosis, with the first product being the MilliDrop Analyzer for cell culture. Validation has been achieved for screening algae, fungi, bacteria, yeasts, and antimicrobial susceptibility testing.

Millidrop's top competitors include 10X Genomics, Mission Bio and Cellares.

Millidrop offers MilliDrop AzurEvo, OT-2 Liquid Handler, Bolt ELISA Analyzer, and ThunderBolt ELISA Analyzer.

Millidrop has 4 investors. Key investors include Bpifrance, European Union, EIC Fund, and Seventure Partners.

Millidrop operates through Gold Standard Diagnostics Budapest Kft..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available